glp 1 mechanism Glucagon-like peptide (GLP-1) GLP-1 receptor agonists review and
Description
BernsmeierCMeyer-GerspachACBlaserLSJekerLSteinertREHeimMHet al
10.3389/fendo.2022.910256 [DOI] [PMC free article] [PubMed] [Google Scholar] 78.Shi W, Zhang W, Zhang D, Ren G, Wang P, Gao L, et al
Key Market Trends & Highlights The GLP-1 drug market is experiencing robust growth driven by increasing demand for innovative therapies and digital health integration
The case settled in March 2026: Novo dropped the lawsuit in exchange for Hims agreeing to transition its platform entirely to authorized, branded semaglutide products and to cease all advertising of compounded GLP-1 alternatives
[DOI] [PubMed] [Google Scholar] 9.Yen F.S., Yang Y.C., Hwu C.M., Wei J.C., Huang Y.H., Hou M.C., Hsu C.C
The other authors declare no conflicts of interest
